United States HR 5463: Drug Pricing Transparency and Accountability Act

Status: Referred to the Subcommittee on Health. (as of 2021-10-01)

State: United States · Session: 117 · Bill: HR 5463

Sponsors: Matthew M. Rosendale

View United States HR 5463 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.